InvestorsHub Logo
Followers 18
Posts 943
Boards Moderated 0
Alias Born 03/23/2011

Re: breezy1 post# 99643

Monday, 04/21/2014 12:18:44 PM

Monday, April 21, 2014 12:18:44 PM

Post# of 130507
In-Licensed Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine from PGI Drug Discovery
What is the market size for Levadopa-Induced Dyskinesia

Please Add to Shareholders Questions
Announced Positive Phase 2a Data for Eltoprozine in LID
What is the market size for Eltoprozine?

Established LymPro research collaboration with Boston University School of Medicine
What time lines have Boston University given on LymPro Research completion.

Announced positive Phase 2a Data for Eltoprazine in adult ADHD
Market Size for Eltoprazine in adult ADHD

Acquired exclusive option to license intellectual property for use of MANF and CDNF to treat Antibiotic-Induced Ototoxicity
Market size for MANF and CDNF to treat Antibiotic-Induced Ototoxicity


What other types of diagnosis treatments can be expeceted to be released for MANF in 2014 and how long to develop?